Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
Vanguard Capital Management reported beneficial ownership of 5,847,224 shares of Globe Life Inc. common stock, representing 7.45% of the class as disclosed in a Schedule 13G.
The filing states Vanguard has sole voting power for 697,232 shares and sole dispositive power for 5,847,224 shares. The filing lists Globe Life's CUSIP 37959E102 and the reporting address for Vanguard Capital Management.
Globe Life Inc. Co-Chairman & CEO James Matthew Darden reported an option exercise and related share sale in company stock. On April 28, 2026, he exercised 4,663 Employee Stock Options at $100.74 per share and acquired the same number of common shares.
The same day, he executed an open-market sale of 4,663 common shares at an average price of about $153.88 per share, with sale prices ranging from $153.635 to $154.24. Following these transactions, he holds 58,451.4598 common shares directly and 4,185.5150 common shares indirectly through a 401(k) plan. He also retains 22,019 stock options after the exercise.
Vanguard Portfolio Management reported beneficial ownership of 4,269,535 shares of Globe Life Inc. common stock, representing 5.44% of the class. The filing shows sole voting power for 15,432 shares and sole dispositive power for 4,269,535 shares. The Form is signed by Ashley Grim on 04/29/2026.
Globe Life Inc. Co‑Chairman & CEO James Matthew Darden reported an option exercise and related share sale. He exercised 18,318 shares of common stock via employee stock options at $100.7400 per share, then completed an open‑market sale of 18,318 shares at an average price of $145.1029 per share.
Footnotes state the sale prices ranged from $145.00 to $145.275 per share. After these transactions, he directly holds 58,451.4598 shares of common stock, plus 4,185.5850 shares held indirectly through a 401(k) Plan, and 26,682 employee stock options remain outstanding.
GLOBE LIFE INC. executive vice president and chief strategy officer Michael Clay Majors reported an exercise-and-sell transaction in company stock. He exercised 34,000 employee stock options at an exercise price of $98.32 per share, converting them into common shares.
On the same date, he completed open-market sales totaling 34,000 common shares in multiple trades. Reported sale prices include specific executions such as $154.4305 per share, with footnotes noting price ranges from $152.325 to $155.05 per share across the different sale tranches.
GLOBE LIFE INC. senior vice president and chief accounting officer Michael Shane Henrie exercised employee stock options and sold common shares. He exercised options for 3,065 shares of common stock at a conversion price of $120.49 per share, fully eliminating this option position.
On the same date, he completed open-market sales totaling 3,591 shares of common stock at prices around $154.35–$154.89 per share. After these transactions, he directly holds 3,449.0833 common shares and indirectly holds 158.2240 common shares through a 401(k) plan.
Globe Life Inc. reported a Form 144 notice for the sale of 34,000 shares of Common Stock, relating to a stock option exercise reported on 04/24/2026. The filing lists prior sales on 02/06/2026 of 27,000 shares for $3,968,653.77 and 3,000 shares for $438,169.44. The broker listed is Apex Clearing in Dallas. The filing states proceeds are from a Stock Option Exercise.
Globe Life submitted a Rule 144 notice reporting insider disposition activity of common stock related to stock option exercises. The filing lists sales of 9,527 shares for $1,375,110.03 on 02/27/2026 and 18,318 shares for $2,657,994.92 on 03/04/2026.
Globe Life Inc. reported solid first quarter 2026 growth, with net income of $3.39 per diluted share, up from $3.01 a year earlier, and net operating income of $3.43 per diluted share, up from $3.07. Total premium revenue rose to $1.27 billion, a 6% increase, driven by 3% growth in life premium and 13% growth in health premium.
Return on equity was strong: net income ROE reached 17.9%, while net operating income ROE excluding AOCI was 14.0%. Book value per share was $77.03, up 19%, and $98.56 excluding AOCI, up 12%. Life net sales increased 6% and health net sales 58%, with notable gains in the United American and Family Heritage divisions.
The company repurchased 1.4 million shares for $203 million at an average price of $141.24 and raised full-year 2026 earnings guidance to a range of $15.40–$15.90 per share, an increase of $0.35 at the midpoint.
GLOBE LIFE INC. EVP & Chief Talent Officer Rebecca E. Zorn exercised stock options and sold shares in a linked set of transactions. She exercised 8,800 Employee Stock Options at an exercise price of $98.32 per share, receiving an equal number of Globe Life common shares.
On the same date, she sold a total of 8,800 common shares in open‑market transactions at prices ranging from about $135.23 to $137.88 per share, including blocks at $135.6593, $136.7147, and $137.4038. After these transactions, she directly held 17,797.0997 Globe Life common shares. Footnotes state detailed price breakdowns are available upon request.